James Rolke - Feb 25, 2023 Form 4 Insider Report for REVELATION BIOSCIENCES, INC. (REVB)

Role
Chief Executive Officer, Director
Signature
/s/ J.P. Galda, as attorney-in-fact for James Rolke
Stock symbol
REVB
Transactions as of
Feb 25, 2023
Transactions value $
$0
Form type
4
Date filed
2/28/2023, 03:08 PM
Previous filing
Jan 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REVB Stock Option (Right to Buy) Award $0 +2.54K $0.00* 0 Feb 25, 2023 Common Stock 2.54K $49.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options were granted on 2/25/2022 and vest 25% on the one-year anniversary of the grant date, and thereafter quarterly over a three-year period, subject to continued service through each such vesting date.